Ellume announces high-performance test for active COVID-19 infection

Ellume announces high-performance test for active COVID-19 infection

Highlights New high-performance antigen test for active COVID-19 infection, developed by Ellume, provides accurate results in less than 15 minutes Builds on existing QIAGEN partnership to bring another test to market to join the rapid, reliable COVID antibody test as announced last month Easy to use; each device can process over 30 samples per hour, […]
Read More

ABC Radio Brisbane Interview with Ellume CEO, Dr Sean Parsons

31 August 2020, Kelly Higgins-Devine Ellume Founder, CEO and Managing Director Dr Sean Parsons was recently interviewed by ABC Brisbane Radio’s Kelly Higgins-Devine about how its innovative digital diagnostics are responding to the COVID-19 pandemic. This interview originally appeared on ABC Brisbane radio, “Mornings” program on 31st August 2020. Listen to the full Mornings episode […]
Read More
Antibody test lab has designs on going global

Antibody test lab has designs on going global

30 August 2020, Robyn Ironside This article originally appeared in The Australian, print and online, on 30th August 2020. View the original article here on The Australian website. A Brisbane laboratory anticipating huge global demand for COVID tests is building a facility capable of producing 15 million tests a month. Ellume Health has already received […]
Read More
Ellume announces global partnership with QIAGEN for COVID-19 diagnosis

Ellume announces global partnership with QIAGEN for COVID-19 diagnosis

Highlights Ellume builds on existing partnership with global diagnostics company QIAGEN, to bring a rapid, reliable COVID antibody test to market Access Anti-SARS-CoV-2 Total serology test has been submitted for US FDA Emergency Use Authorization 900,000 tests pre-ordered Brisbane, Australia – 25 August 2020 Digital diagnostics firm Ellume Ltd (Ellume or “the Company”) has extended […]
Read More
World TB Day 2020

World TB Day 2020

#ItsTimeToEndTB: Diagnostics are critical in infectious disease control Written by Dr Sean Parsons, CEO Ellume. As the world rallies to curb the spread of COVID-19, this year’s World Tuberculosis Day serves as a stark reminder that the two major biological threats to humans are pandemic viruses (like COVID-19) and tuberculosis (TB) – especially multi-drug resistant […]
Read More
Ellume appoints Joanne Moss to its Board as Non-executive Director

Ellume appoints Joanne Moss to its Board as Non-executive Director

Brisbane, Australia – 12 November 2019 Ellume Limited (Ellume) is pleased to announce the appointment of Ms Joanne Moss to its Board as an Independent Non-Executive Director and Chair of Audit and Risk, effective immediately. This appointment supports Ellume’s commitment to good governance and strengthens management resources in preparation for US commercialisation and potential upcoming […]
Read More
How Digital Diagnostics Are Changing Healthcare

How Digital Diagnostics Are Changing Healthcare

The Importance of Accurate Tests to Good Medicine – Despite advances in healthcare over recent decades, infectious diseases remain burdensome illnesses. Influenza kills more people in America than car accidents, tuberculosis kills over 5,000 people every day around the world, and antimicrobial resistance is a growing threat.
Read More
Ellume shines at AFR BOSS’ Most Innovative Companies Awards

Ellume shines at AFR BOSS’ Most Innovative Companies Awards

We’re excited to announce Ellume was recognised as one of Australia and New Zealand’s Most Innovative Companies in 2019, ranking #2 on the Health and Pharmaceutical list published by The Australian Financial Review and Boss Magazine. The prestigious annual list is based on a rigorous  assessment process managed by Australia’s leading innovation consultancy, Inventium, in […]
Read More